Mabion SA

Mabion SA is a leading biotechnology company headquartered in Poland, specializing in the development and production of biosimilar drugs. Our mission is to provide affordable and high-quality treatments for patients suffering from a range of diseases, including cancer, autoimmune disorders, and infectious diseases. We employ innovative technologies and state-of-the-art facilities to create biosimilars that are highly similar to their reference products in terms of safety, efficacy, and quality. Our portfolio includes several biosimilar candidates in various stages of development, such as MabionCD20, MabionHER2, and MabionIL2. At Mabion SA, we are dedicated to improving the lives of patients worldwide by providing them with access to safe and effective treatments that meet their healthcare needs.